Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Canopy Growth Corp

CGC · Nasdaq · CIK 0001737927 · Healthcare · Drug Manufacturers—Specialty & Generic

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

21 Form 4 transaction lines observed in the same window
14 sales · 7 option, withholding, award, gift or other lines

Last qualifying purchase2025-09-22 · Mongeau Luc · $50.0K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Stewart Thomas CarltonSee Remarks
○▼▼▼
Yanofsky TheresaDirector
○▼▼
Lazzarato David AngeloDirector
○▼▼
BAYERN JOSEPHDirector
○▼▼
ATKINS M SHANDirector
○▼▼
Gedeon ChristelleSee Remarks
○▼▼
● Purchase▼ Sale○ Other

Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-09-22 · Mongeau Luc.

Recent Form 4 activity

0Purchases
17Sales
8Other Form 4 lines
22SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING14 sale line(s) · context only
OTHER7 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
27,244,377
Previous report
27,978,911
Avg daily volume
2,090,521
Days to cover
13.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-09-22Mongeau LucPurchase (P)Common Shares27,469USD 1.82USD 49,994SEC filing ↗

Form 4 evidence

25 transaction lines in the latest 365-day window; 182 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-28Yanofsky TheresaSale (S)Common Shares14,920USD 0.93USD 13,876SEC filing ↗
2026-09-28Lazzarato David AngeloSale (S)Common Shares22,380USD 0.93USD 20,813SEC filing ↗
2026-09-28BAYERN JOSEPHSale (S)Common Shares3,096USD 0.93USD 2,879SEC filing ↗
Show recent Form 4 evidence (25 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-28Yanofsky TheresaSale (S)Common Shares14,920USD 0.93USD 13,876SEC filing ↗
2026-09-28Lazzarato David AngeloSale (S)Common Shares22,380USD 0.93USD 20,813SEC filing ↗
2026-09-28BAYERN JOSEPHSale (S)Common Shares3,096USD 0.93USD 2,879SEC filing ↗
2026-09-28ATKINS M SHANSale (S)Common Shares3,096USD 0.93USD 2,879SEC filing ↗
2026-09-17Stewart Thomas CarltonSale (S)Common Shares25,755USD 0.93USD 23,952SEC filing ↗
2026-08-24Stewart Thomas CarltonSale (S)Common Shares2,231USD 1.47USD 3,280SEC filing ↗
2026-08-24Gedeon ChristelleSale (S)Common Shares13,344USD 1.47USD 19,616SEC filing ↗
2026-06-26Yanofsky TheresaSale (S)Common Shares15,054USD 0.92USD 13,850SEC filing ↗
2026-06-26Lazzarato David AngeloSale (S)Common Shares22,674USD 0.92USD 20,860SEC filing ↗
2026-06-26BAYERN JOSEPHSale (S)Common Shares3,197USD 0.92USD 2,941SEC filing ↗
2026-06-26ATKINS M SHANSale (S)Common Shares3,197USD 0.92USD 2,941SEC filing ↗
2026-06-17Yanofsky TheresaAward / grant (A)Common Shares108,324USD 0.00USD 0SEC filing ↗
2026-06-17Stewart Thomas CarltonSale (S)Common Shares9,285USD 0.97USD 9,006SEC filing ↗
2026-06-17Stewart Thomas CarltonAward / grant (A)Common Shares379,018USD 0.00USD 0SEC filing ↗
2026-06-17Mongeau LucSale (S)Common Shares135,231USD 0.97USD 131,174SEC filing ↗
2026-06-17Mongeau LucAward / grant (A)Common Shares1,056,152USD 0.00USD 0SEC filing ↗
2026-06-17Lazzarato David AngeloAward / grant (A)Common Shares162,485USD 0.00USD 0SEC filing ↗
2026-06-17Gedeon ChristelleSale (S)Common Shares58,994USD 0.97USD 57,224SEC filing ↗
2026-06-17Gedeon ChristelleAward / grant (A)Common Shares396,012USD 0.00USD 0SEC filing ↗
2026-06-17BAYERN JOSEPHAward / grant (A)Common Shares108,324USD 0.00USD 0SEC filing ↗
2026-06-17ATKINS M SHANAward / grant (A)Common Shares108,324USD 0.00USD 0SEC filing ↗
2026-02-11Mongeau LucSale (S)Common Shares9,376USD 1.06USD 9,939SEC filing ↗
2025-12-31Yanofsky TheresaSale (S)Common Shares10,434USD 1.13USD 11,790SEC filing ↗
2025-12-31Lazzarato David AngeloSale (S)Common Shares15,715USD 1.13USD 17,758SEC filing ↗
2025-11-11BAYERN JOSEPHAward / grant (A)Common Shares42,658USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerCGC
CIK0001737927
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2833 Medicinal Chemicals & Botanical Products
ExchangeNasdaq

Data coverage

Local Form 4 history182 transaction lines from 2020-05-01 to 2026-09-28
1 P purchase lines · 79 S sale lines · 102 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.